The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 08, 2017
Sirnaomics announced the FDA has granted Orphan-drug designation to STP705 for the treatment of Cholangiocarcinoma.
read more
Friday, December 08, 2017
Scientists from SRI International and Collaborations Pharmaceuticals led a study that used machine learning methods to identify tilorone ...
read more
Wednesday, December 13, 2017
Amgen announced new results showing the positive overall survival findings from the final analysis of the Phase 3 ASPIRE trial.
read more
Wednesday, December 13, 2017
Regeneron and Sanofi announced positive topline results from a pivotal Phase 2 clinical study of cemiplimab in 82 patients with advanced CSCC.
read more
Wednesday, December 13, 2017
Sirenas has received a new grant from the Bill & Melinda Gates Foundation to advance ATLANTIS, the company's proprietary drug discovery technology.
read more
Friday, December 15, 2017
Amgen and LabCentral announced that Kernal Biologics and QurAlis have won the Amgen Golden Ticket at LabCentral.
read more
Tuesday, December 19, 2017
In recent years, the medical community has experienced a shift in the way health care is practiced.
read more
Friday, December 29, 2017
Twice a year the federal government publishes the Unified Agenda which provides the American public with insight into regulations under development or...
read more
Tuesday, January 09, 2018
Biohaven announced positive results from its bioequivalence study with BHV-0223, a sublingual formulation of riluzole.
read more
Wednesday, January 10, 2018
The FDA has agreed to allow Mayo Clinic to use an automated bioreactor-based stem cell production platform on its campus in Jacksonville, Florida.
read more
Wednesday, January 24, 2018
BioAtla announced the U.S. Food and Drug Administration (FDA) has cleared BioAtla's Investigational New Drug application (IND) for BA3011.
read more
Thursday, February 08, 2018
Novo Nordisk announced that Rebinyn, Coagulation Factor IX (Recombinant), GlycoPEGylated, is now available in the United States for the treatment of ...
read more
Friday, February 09, 2018
BI 409306 was investigated in two studies (NCT 02240693 and NCT 02337907), designed to show superiority of BI 409306 over placebo in cognition. ...
read more
Friday, February 23, 2018
Kite and Sangamo announced the companies have entered into a worldwide collaboration using Sangamo’s ZFN technology platform for the development of ...
read more
Monday, February 26, 2018
Yisheng Biopharma announced the FDA has granted ODD for its lead immuno-oncology candidate, YS-ON-001, for the treatment of pancreatic cancer.
read more